By Braden Campbell ( October 28, 2016, 1:53 PM EDT) -- Latham & Watkins LLP guided Japanese drugmaker Astellas Pharma Inc. through its agreement on Friday to buy venture capital-backed German cancer drug developer Ganymed Pharmaceuticals AG in a cash deal that could pay Ganymed shareholders as much as €1.28 billion ($1.4 billion), the companies said....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.